|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
05/01/2024 |
$1.17 |
$1.22 |
$1.12 |
$1.21 |
355.30K | 05/02/2024 |
$1.16 |
$1.20 |
$1.16 |
$1.16 |
218.90K | 05/03/2024 |
$1.17 |
$1.19 |
$1.13 |
$1.14 |
231.60K | 05/06/2024 |
$1.13 |
$1.16 |
$1.07 |
$1.11 |
1.01M | 05/07/2024 |
$1.13 |
$1.16 |
$1.12 |
$1.14 |
225.80K |
|
Protalix BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system. Co.'s proprietary ProCellEx platform is being used to manufacture its marketed product, Elelyso®, for the treatment of Gaucher disease. Co. is also developing, via ProCellEx, a pipeline of products. Co.'s clinical development program for pegunigalsidase alfa, or PRX-102, for the potential treatment of Fabry disease. In addition, Co. is developing uricase, or PRX-115, for the treatment of refractory gout. | |
|
Protalix BioTherapeutics (PLX) has the following price history information. Looking back at PLX historical stock prices for the last five trading days, on May 01, 2024, PLX opened at $1.17, traded as high as $1.22 and as low as $1.12, and closed at $1.21. Trading volume was a total of 355.30K shares. On May 02, 2024, PLX opened at $1.16, traded as high as $1.20 and as low as $1.16, and closed at $1.16. Trading volume was a total of 218.90K shares. On May 03, 2024, PLX opened at $1.17, traded as high as $1.19 and as low as $1.13, and closed at $1.14. Trading volume was a total of 231.60K shares. On May 06, 2024, PLX opened at $1.13, traded as high as $1.16 and as low as $1.07, and closed at $1.11. Trading volume was a total of 1.01M shares. On May 07, 2024, PLX opened at $1.13, traded as high as $1.16 and as low as $1.12, and closed at $1.14. Trading volume was a total of 225.80K shares.
PLX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Protalix BioTherapeutics shares, starting with a $10,000 purchase of PLX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/09/2014 |
|
End date: |
05/07/2024 |
|
Start price/share: |
$38.50 |
|
End price/share: |
$1.14 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.04% |
|
Average Annual Total Return: |
-29.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$296.21 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
05/01/2024 | $1.21 | 05/02/2024 | $1.16 | 05/03/2024 | $1.14 | 05/06/2024 | $1.11 | 05/07/2024 | $1.14 |
|
|